Insiders / Collins Helen Louise
Collins Helen Louise
CIK 1701247personinsider
Companies
1
First seen
Feb 17, 2026
Last activity
Mar 27, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Enliven Therapeutics, Inc. · ELVN | 25,000 | — |
All securities held
2 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| Enliven Therapeutics, Inc. | Common Stock | 25,000 |
| Enliven Therapeutics, Inc. | Stock Option (right to buy)Derivative | 136,268 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $1.40M | -40K -61.54% | 25,000 0.03% of shares | medium |
| Feb 17, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $1.18M | -45K -64.29% | 25,000 0.03% of shares | medium |
| Mar 9, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $896.8K | -30K -54.44% | 25,000 0.03% of shares | medium |
| Mar 10, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $305.8K | -10K -28.83% | 25,000 0.03% of shares | medium |
| Mar 17, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $138.8K | -5K -16.67% | 25,000 0.03% of shares | medium |
| Feb 17, 2026 | Exercise | ELVN Enliven Therapeutics, Inc. Common Stock | $111.6K | +45K +180.00% | 70,000 0.10% of shares | low |
| Mar 25, 2026 | Exercise | ELVN Enliven Therapeutics, Inc. Common Stock | $99.2K | +40K +160.00% | 65,000 0.09% of shares | low |
| Mar 9, 2026 | Exercise | ELVN Enliven Therapeutics, Inc. Common Stock | $74.1K | +30K +119.48% | 54,871 0.07% of shares | low |
| Mar 10, 2026 | Exercise | ELVN Enliven Therapeutics, Inc. Common Stock | $25.1K | +10K +40.52% | 35,129 0.05% of shares | low |
| Mar 17, 2026 | Exercise | ELVN Enliven Therapeutics, Inc. Common Stock | $12.4K | +5K +20.00% | 30,000 0.04% of shares | low |